DelveInsight has launched a new report on Diabetic foot ulcers Epidemiology
Diabetic Foot Ulcer (DFU) is one of the most significant and devastating complications of diabetes mellitus, and probably the major component of the diabetic foot. According to American Podiatric Medical Association (APMA), diabetes is the leading cause of non-traumatic lower extremity amputations in the United States, and approximately 14-24% of patients with diabetes who develop a foot ulcer will require an amputation. Foot ulceration precedes 85% of diabetes-related amputations.
DelveInsight’s ‘Diabetic foot ulcers Epidemiology Forecast to 2030’ report conveys an inside and out comprehension of the sickness, authentic and anticipated Diabetic foot ulcers (DFUs) the study of disease transmission in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Click here to get free sample copy- https://www.delveinsight.com/sample-request/diabetic-foot-ulcers-dfus-market
Diabetic foot ulcers Epidemiology
Diabetic foot ulcers are divided into two groups, namely: Neuropathic ulcers (feet is warm, perfusion is still good with pulsation still palpable, and perspiration is reduced, skin dry and cracked). Neuroischemic ulcers (feet is colder, not palpable pulsation, thin skin, smooth, and without hair, subcutaneous tissue atrophy, intermittent claudication, and rest pain may not be present due to neuropathy).
Diabetic foot ulcers Epidemiology key facts
- In 2003, the Centers for Disease Control and Prevention (CDC), based on the National Hospital Discharge Survey, reported a rate of 8 (age 65–74) to 11 (age 75 and greater) hospital discharges with a diagnosis of foot ulcer per 1000 individuals with diabetes.
- According to global meta-analysis study conducted by Zhang P et al., it was estimated that the global diabetic foot ulcer prevalence was 6.3%, which was higher in males than in females and higher in type 2 diabetic patients (6.4%, 95%CI: 4.6-8.1%) than in type 1 diabetics (5.5%, 95%CI: 3.2-7.7%) (2015).
- Zhang P et al. also estimates that, North America had the highest prevalence (13.0%, 95%CI: 10.0-15.9%), Oceania had the lowest (3.0%, 95% CI: 0.9-5.0%), and the prevalence in Europe, and Africa were 5.1% and 7.2%, respectively (2015).
- According to Faris G. Bakri et al., Diabetic foot ulcers are a major cause for diabetic foot infection. About 10-30% of diabetic patients with a foot ulcer will eventually progress to an amputation. The prevalence of foot ulcers among diabetic patients ranges from 2% to 12%. In addition, the lifetime risk of a diabetic person developing a foot ulcer could be as high as 25% (2011).
Diabetic foot ulcers Epidemiology Segmentation
- Total Prevalent Cases of Diabetic Foot Ulcers (DFU) in the 7MM (2017-2030)
- Gender-Specific Prevalent Cases of Diabetic Foot Ulcers in the 7MM (2017-2030)
- Diagnosed and Treatable Cases of Diabetic Foot Ulcers in the 7MM (2017-2030)
Diabetic foot ulcers Epidemiology Report Scope
- The Diabetic foot ulcers report covers an itemized outline clarifying its causes, indications, and characterization, pathophysiology, analysis and treatment designs
- The Diabetic foot ulcers Epidemiology Report and Model give a diagram of the danger factors and worldwide patterns of Diabetic foot ulcers in the seven significant business sectors (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
- The Diabetic foot ulcers report gives knowledge about the chronicled and estimated tolerant pool of Diabetic foot ulcers in seven significant business sectors covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
- The Diabetic foot ulcers report assists with perceiving the development openings in the 7MM as for the patient populace
- The Diabetic foot ulcers report surveys the infection danger and weight and features the neglected requirements of Diabetic foot ulcers
- The Diabetic foot ulcers report gives the division of the Diabetic foot ulcers the study of disease transmission
Click here to get free sample copy- https://www.delveinsight.com/sample-request/diabetic-foot-ulcers-dfus-market
Table of content
1. Key Insights
2. Executive Summary of Diabetic foot ulcers (DFUs)
3. Diabetic foot ulcers (DFUs): Disease Background and Overview
4. Patient Journey
5. Epidemiology and Patient Population
6. Treatment Algorithm, Current Treatment, and Medical Practices
7. KOL Views
8. Unmet Needs
9. Appendix
10. DelveInsight Capabilities
11. Disclaimer
12. About DelveInsight
Reasons to buy this Diabetic foot ulcers report
- Create business procedures by understanding the patterns forming and driving the worldwide Diabetic foot ulcers market
- Measure tolerant populaces in the worldwide Diabetic foot ulcers market to improve item configuration, estimating, and dispatch plans
- Arrange deals and advertising endeavors by distinguishing the age gatherings and sex that present the best open doors for Diabetic foot ulcers therapeutics in every one of the business sectors covered
- Comprehend the extent of Diabetic foot ulcers population by it’s the study of disease transmission
- The Diabetic foot ulcers Epidemiology Model created by DelveInsight is anything but difficult to explore, intelligent with dashboards, and the study of disease transmission based with straightforward and steady strategies. Besides, the model backings information introduced in the report and features illness patterns more than 11-year gauge period utilizing respectable sources
View related reports
- Diabetic foot ulcers Market
- Diabetic Foot Ulcers Pipeline
Contact us
Shruti Thakur
info@delveinsight.com
+91-9650213330
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/